Order Article Reprints

Estrada JA, Cheng C-Y, Ku S-Y, Hu H-C, Yeh H-W, Lin Y-C, Chen C-P, Cheng S-H, Janssen R, Lin I-F. An Immunobridging Study to Evaluate the Neutralizing Antibody Titer in Adults Immunized with Two Doses of Either ChAdOx1-nCov-19 (AstraZeneca) or MVC-COV1901. Vaccines. 2022; 10(5):655. https://doi.org/10.3390/vaccines10050655

Estrada, Josue Antonio, Chien-Yu Cheng, Shin-Yen Ku, Hui-Chun Hu, Hsiu-Wen Yeh, Yi-Chun Lin, Cheng-Pin Chen, Shu-Hsing Cheng, Robert Janssen, and I-Feng Lin. 2022. "An Immunobridging Study to Evaluate the Neutralizing Antibody Titer in Adults Immunized with Two Doses of Either ChAdOx1-nCov-19 (AstraZeneca) or MVC-COV1901" Vaccines 10, no. 5: 655. https://doi.org/10.3390/vaccines10050655

Estrada, J. A., Cheng, C.-Y., Ku, S.-Y., Hu, H.-C., Yeh, H.-W., Lin, Y.-C., Chen, C.-P., Cheng, S.-H., Janssen, R., & Lin, I.-F. (2022). An Immunobridging Study to Evaluate the Neutralizing Antibody Titer in Adults Immunized with Two Doses of Either ChAdOx1-nCov-19 (AstraZeneca) or MVC-COV1901. Vaccines, 10(5), 655. https://doi.org/10.3390/vaccines10050655